jCell
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for jCell, covering 2019-03-05 to 2023-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa [Phase 2]